Showing results (81-90 of 161) with videos related to
Sort By:
Pageof 17
Case Reports in Oncology|April 24, 2019
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the LiteratureNikhil Agrawal, Arjun Khunger, Pankit Vachhani, et al.International Journal of Cardiology|October 2, 2015
Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF studyCecilia Linde, Anne B Curtis, Gregg C Fonarow, et al.Journal of the American Heart Association|November 7, 2012
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HFGregg C Fonarow, Nancy M Albert, Anne B Curtis, et al.Journal of the American College of Cardiology|January 14, 2022
Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art ReviewAnnabelle Santos Volgman, Gatha Nair, Radmila Lyubarova, et al.Journal of the American College of Cardiology|October 19, 2004
Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, CaliforniaAnne B Curtis, William T Abraham, Peng-Sheng Chen, et al.Journal of the American College of Cardiology|December 20, 2005
Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study programAngel R León, William T Abraham, Anne B Curtis, et al.JACC. Clinical Electrophysiology|March 23, 2024
Mortality Benefit Among Primary Prevention Implantable Cardioverter-Defibrillator Recipients on Contemporary Heart Failure TreatmentAamir Ahmed, Angelo Auricchio, Suneet Mittal, et al.Seminars in Dialysis|October 6, 2009
Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center studyArif Asif, Loay Salman, Roger G Carrillo, et al.Pacing and Clinical Electrophysiology : PACE|December 23, 2009
Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndromeDan Hu, Hector Barajas-Martinez, Vladislav V Nesterenko, et al.Journal of the American College of Cardiology|February 12, 2011
Systematic review of the incidence of sudden cardiac death in the United StatesMelissa H Kong, Gregg C Fonarow, Eric D Peterson, et al.Pageof 17